Literature DB >> 2210382

Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system.

D W Kim1, T Uetsuki, Y Kaziro, N Yamaguchi, S Sugano.   

Abstract

We have characterized the promoter region of the human elongation factor 1 alpha-encoding gene (EF-1 alpha) and developed a versatile expression system which has a wide host range and a high efficiency of gene expression. To identify the promoter region of the EF-1 alpha gene necessary for efficient gene expression, we constructed four pEF-CAT plasmids that have the bacterial cat gene fused to four different sites of the human EF-1 alpha gene: (i) ligated to the end of the TATA box (pEF220-CAT); (ii) ligated in exon 1 (pEF204-CAT and pEF233-CAT), and (iii) ligated in exon 2 (pEF321-CAT). All the pEF-CAT plasmids were highly expressed in all the cell types tested, including fibroblasts and lymphoid cells. Plasmid pEF321-CAT, which contains the first exon and the first intron, gave the highest level of cat expression. Plasmids pEF204- and pEF233-CAT, which contain part of the first exon but do not contain the first intron, were less efficient in cat expression than was pEF321-CAT. Plasmid pEF220-CAT, which lacks both the first exon and the first intron, was the least efficient. Plasmid pEF321-CAT was several- to 100-fold more efficient in cat expression than plasmid pSV2-CAT depending on the recipient cell types. The promoter of pEF321 plasmid also directed the stable expression of the bacterial neo gene more efficiently than the promoter of the simian virus 40 (SV40) early gene or the long terminal repeat of Rous sarcoma virus. Using this system, the SV40 early gene and the cDNA encoding human CD4 were also expressed efficiently.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210382     DOI: 10.1016/0378-1119(90)90091-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  75 in total

1.  Inside the mouse hospital: science, animal welfare and strife in the drive for AAALAC accreditation.

Authors:  V Hampshire; J Davis
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

2.  Internal ribosome entry site-mediated translation of Smad5 in vivo: requirement for a nuclear event.

Authors:  Kazuko Shiroki; Chieko Ohsawa; Natuki Sugi; Motoaki Wakiyama; Kin-ichiro Miura; Manabu Watanabe; Yutaka Suzuki; Sumio Sugano
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

3.  Simultaneous on/off regulation of transgenes located on a mammalian chromosome with Cre-expressing adenovirus and a mutant loxP.

Authors:  Saki Kondo; Aya Okuda; Hiromi Sato; Naoto Tachikawa; Miho Terashima; Yumi Kanegae; Izumu Saito
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

4.  Stable production of an analog of human tissue plasminogen activator from cultured Drosophila cells.

Authors:  M K Olsen; S K Rockenbach; H D Fischer; J G Hoogerheide; C S Tomich
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

5.  Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors.

Authors:  Makoto Yoshimitsu; Takeya Sato; Kesheng Tao; Jagdeep S Walia; Vanessa I Rasaiah; Gillian T Sleep; Gary J Murray; Armando G Poeppl; John Underwood; Lori West; Roscoe O Brady; Jeffrey A Medin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-18       Impact factor: 11.205

6.  Stability and homogeneity of transgene expression in isogenic cells.

Authors:  Weimin Liu; Yuanzhu Xiong; Manfred Gossen
Journal:  J Mol Med (Berl)       Date:  2005-11-18       Impact factor: 4.599

7.  Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.

Authors:  Incilay Sinici; Maryam Zarghooni; Michael B Tropak; Don J Mahuran; H Asuman Ozkara
Journal:  Biochem Genet       Date:  2006-04-28       Impact factor: 1.890

Review 8.  A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.

Authors:  Harjeet Singh; Helen Huls; Partow Kebriaei; Laurence J N Cooper
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  Sequence and promoter analysis of the highly expressed TEF gene of the filamentous fungus Ashbya gossypii.

Authors:  S Steiner; P Philippsen
Journal:  Mol Gen Genet       Date:  1994-02

10.  Transcriptional burst frequency and burst size are equally modulated across the human genome.

Authors:  Roy D Dar; Brandon S Razooky; Abhyudai Singh; Thomas V Trimeloni; James M McCollum; Chris D Cox; Michael L Simpson; Leor S Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.